09.15.14
Livingston, N.J.-based Milestone Scientific Inc.’s subsidiary, Milestone Medical, has earned the CE mark for its intra-articular injection instrument.
“Receipt of regulatory approval in Europe for this instrument is validation of our technology and allows our subsidiary to move forward with its plans to commercialize the technology in Europe,” said CEO of Milestone Scientific Leonard Osser. “Our subsidiary is now in the process of evaluating potential strategic partners to distribute its intra-articular instrument in Europe. We believe we are well positioned to enter this multi-billion dollar market since conventional injections are painful, a problem eliminated with our instrument, and not always efficacious, as doctors often fail to locate the intra-articular space or use inappropriate volumes of hyaluronic acid.”
Milestone’s injection technology is based on a patented Dynamic Pressure Sensing system intended to measure the density of body tissue and thus help a clinician know the location of a hypodermic needle during an injection. The system uses computer-controlled technology to provide real-time feedback to the medical practitioner and identify with precision when a needle has reached the location where a drug should be administered to a patient. According to the company, it has the added advantage in other applications of controlling the pain that patients typically associate with injections.
Milestone Scientific is a medical research and development company that designs and patents injection technology.
“Receipt of regulatory approval in Europe for this instrument is validation of our technology and allows our subsidiary to move forward with its plans to commercialize the technology in Europe,” said CEO of Milestone Scientific Leonard Osser. “Our subsidiary is now in the process of evaluating potential strategic partners to distribute its intra-articular instrument in Europe. We believe we are well positioned to enter this multi-billion dollar market since conventional injections are painful, a problem eliminated with our instrument, and not always efficacious, as doctors often fail to locate the intra-articular space or use inappropriate volumes of hyaluronic acid.”
Milestone’s injection technology is based on a patented Dynamic Pressure Sensing system intended to measure the density of body tissue and thus help a clinician know the location of a hypodermic needle during an injection. The system uses computer-controlled technology to provide real-time feedback to the medical practitioner and identify with precision when a needle has reached the location where a drug should be administered to a patient. According to the company, it has the added advantage in other applications of controlling the pain that patients typically associate with injections.
Milestone Scientific is a medical research and development company that designs and patents injection technology.